Listerine With Fluoride Proposed Six-Month Study To Be Reviewed By FDA
This article was originally published in The Tan Sheet
Executive Summary
Pfizer Consumer Healthcare plans to conduct a six-month clinical study involving at least 300 subjects to determine whether adding .02% sodium fluoride to the company's Listerine mouthrinse affects the antiplaque/ antigingivitis effectiveness of the product
You may also be interested in...
FreshBurst Listerine Study Must Exhibit 20% Gingivitis Reduction – FDA
A six-month study of FreshBurst Listerine with Fluoride will need to show "a 20% reduction in gingivitis" over the control to receive agency approval, FDA told Pfizer execs at an Aug. 27 meeting
Listerine meeting postponed
"Feedback" meeting on Pfizer's proposed changes to the OTC anticaries final monograph, originally slated for June 18, will be rescheduled within a month to give Division of OTC Drug Products more time to review relevant material, FDA says June 14. Meeting is part of Pfizer's efforts to amend monograph to allow for a mouthrinse combining essential oils, sodium fluoride (1"The Tan Sheet" June 10, 2002, p. 3)...
W-L Listerine Anticaries Rinse Gingivitis Assessment Required - FDA
Acceptance of plaque reduction as the sole outcome of an experimental gingivitis model conducted to demonstrate the antiplaque/antigingivitis activities of Pfizer/Warner-Lambert's Listerine anticaries mouthrinse would be "premature," FDA tells company.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: